A Mitochondrial Supplement Trial in Autism – A Research Update from Dr. Richard Frye

Dr. Richard E. Frye, MD, PhD
Behavioral Child Neurologist

A Mitochondrial Supplement Trial in Autism – A Research Update from Dr. Richard Frye

Dr. Richard E. Frye walks through a double-blind, placebo-controlled crossover trial of a mitochondrial supplement in children with autism. Paper: Hill et al., “A Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism,” IJMS 2025.

2026-10-01T19:18:16+00:00Presentations and Interviews|

Title

PROFESSIONAL DISCLAIMER

The Site cannot and does not contain medical/health advice. The medical/health information is provided for general informational and educational purposes only and is not a substitute for professional advice. Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of medical/health advice. THE USE OR RELIANCE OF ANY INFORMATION CONTAINED ON THE SITE OR OUR MOBILE APPLICATION IS SOLELY AT YOUR OWN RISK.

Please read the Terms and Conditions document.

Dr. Richard E. Frye, MD, PhD Behavioral Child Neurologist

Dr. Richard E. Frye, MD, PhD Behavioral Child Neurologist